AU616450B2 - A process for the enzymatic hydrolysis of alpha- aminoadipinyl-monoamino compounds - Google Patents
A process for the enzymatic hydrolysis of alpha- aminoadipinyl-monoamino compounds Download PDFInfo
- Publication number
- AU616450B2 AU616450B2 AU27323/88A AU2732388A AU616450B2 AU 616450 B2 AU616450 B2 AU 616450B2 AU 27323/88 A AU27323/88 A AU 27323/88A AU 2732388 A AU2732388 A AU 2732388A AU 616450 B2 AU616450 B2 AU 616450B2
- Authority
- AU
- Australia
- Prior art keywords
- gtp
- aminoadipinyl
- hydrolysis
- formula
- monoamino compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims description 11
- 230000007071 enzymatic hydrolysis Effects 0.000 title description 4
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 title description 4
- 238000000855 fermentation Methods 0.000 claims abstract description 5
- 230000004151 fermentation Effects 0.000 claims abstract description 5
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims description 8
- 235000015097 nutrients Nutrition 0.000 claims description 8
- 230000007062 hydrolysis Effects 0.000 claims description 7
- 108010016626 Dipeptides Proteins 0.000 claims description 6
- 150000001782 cephems Chemical class 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 150000001781 cephams Chemical class 0.000 claims description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 4
- 244000063299 Bacillus subtilis Species 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000006555 catalytic reaction Methods 0.000 claims 1
- 210000002837 heart atrium Anatomy 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 abstract 1
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 abstract 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical class S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N Cephalosporin C Natural products S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 241000186063 Arthrobacter Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 241000588769 Proteus <enterobacteria> Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- HOKIDJSKDBPKTQ-GLXFQSAKSA-M cephalosporin C(1-) Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H]([NH3+])C([O-])=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-M 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 239000008057 potassium phosphate buffer Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- -1 Siron Inorganic materials 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 2
- 150000002897 organic nitrogen compounds Chemical class 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000005375 photometry Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- BQIMPGFMMOZASS-CLZZGJSISA-N (6r,7r)-7-amino-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(CO)=C(C(O)=O)N2C(=O)[C@@H](N)[C@H]21 BQIMPGFMMOZASS-CLZZGJSISA-N 0.000 description 1
- AGNGYMCLFWQVGX-AGFFZDDWSA-N (e)-1-[(2s)-2-amino-2-carboxyethoxy]-2-diazonioethenolate Chemical compound OC(=O)[C@@H](N)CO\C([O-])=C\[N+]#N AGNGYMCLFWQVGX-AGFFZDDWSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000002024 Gossypium herbaceum Species 0.000 description 1
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 1
- 238000010268 HPLC based assay Methods 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108090000279 Peptidyltransferases Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000589538 Pseudomonas fragi Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- WKDDRNSBRWANNC-ATRFCDNQSA-N Thienamycin Chemical compound C1C(SCCN)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 WKDDRNSBRWANNC-ATRFCDNQSA-N 0.000 description 1
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 description 1
- 241001480015 Trigonopsis variabilis Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229950011321 azaserine Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- QHTOIDKCEPKVCM-ZCFIWIBFSA-N cepham Chemical compound S1CCCN2C(=O)C[C@H]21 QHTOIDKCEPKVCM-ZCFIWIBFSA-N 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 1
- 229960003324 clavulanic acid Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000009295 crossflow filtration Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 230000000937 inactivator Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229940040511 liver extract Drugs 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 210000001322 periplasm Anatomy 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 108010009004 proteose-peptone Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006965 reversible inhibition Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- ZXUCBXRTRRIBSO-UHFFFAOYSA-L tetrabutylazanium;sulfate Chemical compound [O-]S([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC ZXUCBXRTRRIBSO-UHFFFAOYSA-L 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
- C12P35/02—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin by desacylation of the substituent in the 7 position
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
gamma -Glutamyltranspeptidase, which can be prepared by fermentation, can be used to hydrolyse alpha -aminoadipinyl-monoamino compounds, especially D-( delta )- alpha -aminoadipinyl-7-aminocephalosporanic acid.
Description
4; Form COMMONWEALTH OF AUSTRALIA PATENTS ACT 1952-69 COMPLETE SPECIFICATION (ORIGINAL) 616450 616450 Class Int. Class Application Number: Lodged: Complete Specification Lodged: Accepted: Published: *Priority: p Related Art:
C
bO C SName of Applicant: ,Address of Applicant: HOECHST AKTIENGESELLSCHAFT Bruningstrasse, D-6230 Frankfurt/Main Federal Republic of Germany.
Actual Inventor: WERNER ARETZ and KLAUS SAUBER C 0 Address for Service EDWD. WATERS SONS, 50 QUEEN STREET, MELBOURNE, AUSTRALIA, 3000.
Complete Specification for the invention entitled: A PROCESS FOR THE ENZYMATIC HYDROLYSIS OF (c-AMINOADIPINYL- MONOAMINO COMPOUNDS The following statement is a full description of this invention, including the best method of performing it known to 1.
Ata.;^
L~;
la A PROCESS FOR THE ENZYMATIC HYDROLYSIS OF Oa-AMINOADIPINYL- MONOAMINO COMPOUNDS Description A process for the enzymatic hydrolysis of (-aminoadipinyl-monoamino compounds y-Glutamyltranspeptidases (y-GTP hereinafter) play an important part in amino acid metabolism and in the glutathione cycle in animal tissues and in microorganisms [Meth. Enzymol. 77, 237 (1981)]. They are responsible for the transport of various amino acids in the form of their y-glutamyl derivatives, the 1 0 formation of polyglutamic acid in Bacilli, and the breakdown of glutathione (y-glutamylcysteinyl-glycine).
It has already been proposed (EP 0,275,901) to use y-GTP to hydrolyze adipinyl- or glutaryl-monoamino compounds.
It has now been found, surprisingly, that the y-GTP the subject of this invention 1 5 catalyzes the hydrolysis of a-aminoadipinyl-monoamino compounds of the formula I HOOC- CH-(CH 2 3 C-NH-R1 (I) I I I
NH
2
O
S 2 in which R1 denotes amino acids, dipeptides, cephems, cephams or derivatives thereof.
20 This is all the more surprising because it has hitherto been assumed that neither C4 nor C6 side-chains are accepted by the active center of prior art y-GTP (see Agric.
Biol. Chem. 42, 1978, pages 371-81). The y-GTP of the instant invention is able to accept C4 C6 side-chains and moreover C 4 C6 side-chains wherein R1, as defined below, is an amino acid, a dipeptide, cephem, cepham or derivatives thereof.
2 5 Hence the invention relates to: S: 25 1. A y-glutamyltranspeptidase having the following properties o e oo il
I
2 a molecular weight of 40,000 to 80,00, an isoelectric point at pH 4.4 to 5.9, for gLutamyLparanitroanilide as substrate a pH optimum in the range 6.5 to 10, and a Km of 9 to 36 pM at pH 8, and hydrolysis of f.-aminoadipinyl-monoamino compounds of the formuLa I
HOOC-CH-(CH
2 3
-C-NH-R
1
(I)
NH
2
O
in which R1 denotes amino acids, dipeptides, cephems, cephams 2* A or derivatives thereof, 15 2. A process for the preparation of the /J-glutamyltranspeptidase having the properties mentioned in 1., which comprises cultivation of bacteria of the genera Pseudomonas, Proteus, Arthrobacter and Bacillus in a nutrient medium until the said -~-GTP accumulates in 20 the nutrient medium.
3. The use of the J-glutamyltranspeptidase having the properties mentioned in 1. for the hydrolysis of *-aminoadipinyl-monoamino compounds of the formula I.
The invention is described in detail hereinafter, especially in its preferred embodiments. The invention is furthermore defined in the patent claims.
The 4/-glutamyLtranspeptidase 'GTP) catalyzes the hy- Sdrolysis of a-aminoadipinyl-monoamino compounds of the formula I, as defined above, to give the corresponding acid and the monoamino compound. 7-Aminocephalosporanic acid derivatives are preferably used as substrate.
The enzyme occurs in the periplasm of microorganisms and extracellularly and can be characterized by a molecular weight of 40,000 to 80,000, preferably 50,000 to 70,000, C: i-i i 3 especially 55,000 to 65,000, and by an isoelectric point which is at a pH of 4.4 to 5.9, preferably 4.8 to 5.5. The pH optimum for L- y-glutamylparanitroanilide as substrate is in the pH range 6.5 to 10. The transpeptidase according to the invention has a Km for the same substrate of 9 to 36 Im, preferably 15 to 20 pm, in particular 17.8 gim, at pH 8.
The y-GTP according to the invention is irreversibly inhibited in the presence of azaserine or iodoacetamide. The enzyme shows reversible inhibition in the presence of copper, mercury and a mixture of serine and borate, as well as in the presence of 7-aminocephalosporanic acid.
The y-GTP is prepared with the aid of microorganisms, as also described in European Patent Application EP 0,275,901. In this process, bacteria, especially of the genera Pseudomonas, Proteus, Arthrobacter and Bacillus, are cultivaied in a nutrient medium until y-GTP accumulates in the nutrient medium. suitable examples are: Pseudomonas putida ATCC 17390, Pseudomonas aeruginosa NCTC 10701, Proteus 15 vulgaris ATCC 9634, Arthrobacter parafineus ATCC 31917 as well as Pseudomonas fragi o. DSM 3881 and Bacillus subtilis IFO 3025. The enzyme is particularly preferably obtained from Bac. subitlis IFO 3025. Mutants and variants of the said microorganisms Sare also suitable. All the organisms mentioned hereinbefore are reasonably available to the skilled addressee from the institutions mentioned.
20 The microorganisms are cultured aerobically, singly or in mixed culture, for example submerged with shaking or stirring in shaken flasks or fermenters, where appropriate with air or oxygen being passed in. The fermentation can take place in a S temperature range from about 20 to 370C, preferably at about 25 to 30 0 C, in particular S0* at 28 to 300C. Fermentation is carried out in a pH range between 5 and 8.5, preferably 25 between 5.5 and 8.0. Under these conditions, the culture broth shows considerable accumulation of the enzyme in general after 1 to 3 days. Synthesis of the y-GTP starts
O@
in the late log phase and *Goo 4
W
4 reaches its maximum in the stationary phase of growth.
The production of the periplasmic enzyme can be foLLowed with the aid of activity assays by HPLC analysis or photometry.
The nutrient solution used to produce the ^GTP contains 0.2 to 5 preferably 0.5 to 2 organic nitrogen compounds and inorganic salts. Suitable organic nitrogen compounds are: amino acids, peptones, furthermore meat extracts, milled seeds, for example of corn, wheat, beans, soybeans or the cotton plant, distillation residues from the manufacture of alcohol, meat meals or yeast extracts. Examples of inorganic salts which the nutrient 15 solution can contain are chlorides, carbonates, sulfates or phosphates of the alkali metal or alkaline earth metals, Siron, zinc and manganese, but also ammonium salts and nitrates.
20 The addition of assimilable carbohydrates increases the yield of biomass. Carbohydrates are also added in the abovementioned concentrations. It is possible to add as preferred carbon source for example sugars, such as glucose or sucrose, as well as carbohydrate-containing natural- 25 products such as malt extract, to the nutrient solution.
*C
Although the optimal fermentation conditions differ for each microorganism, either they are already known to those skilled in the art or they can be established in easy preliminary tests.
Purification can be carried out by classical processes via lysozyme digestion, ammonium sulfate precipitation, and ion exchange and gel permeation chromatography. The enzyme can be coupled by conventional methods (Colowick and Kaplan, Meth. Enzymol., vol. XLIV).
It is possible to use for the enzymatic reaction both 5 whole cells in free or immobilized form, with the addition of B-Lactamase inactivators, for example clavulanic acid or thienamycin, and the isolated enzyme which can also be carrier-bound. Examples of suitable materials for the immobilization of whole cells are chitosan, alginate, K-carrageenan, polyacryLohydrazides and other known substances fiom processes known from the literature (K.
Venkatsubramanian, Immob. Cells (1979), ACS Symposium Series, page 106).
The hydrolysis reaction is most suitably carried out at *0 about pH 6.6 to 8 and at a temperature of about 28 to 38 0
C.
The preferred compound of the formula I is that in which S 1 R denotes the radical 0•2 1. :CH2 R
COOH
in which R is hydrogen, OH or -O-C-CH 3 The -GTP has industrial importance in particular for obtaining 7-aminocephalosporanic acid from cephalosporin C.
To date however, a yeast (Trigonopsis variabilis) has al- S* ways been used to generate from cephalosporin C glutaryl- 25 7-aminocephalosporanic acid which only then could be hydrolyzed enzymatically, in a second reaction step, to give 7aminocephalosporanic acid. It is now possible with the process according to the invention to prepare 7-aminocephalosporanic acid from cephalosporin C in a single step.
SThe invention is described in more detail in the examples which follow. Unless otherwise indicated, percentage data relate to weight.
Example 1 The -GTP-producing microorganism strains are maintained on agar slants of the following composition:
~I
6 Glucose 1 Casein peptone 0.4 Meat extract 0.4 Yeast extract 0.05 Liver extract 0.05 NaCL 0.25 pH 7.2 The slant tubes are incubated at 28 C for 2 days. The cells are then rinsed off with 10 ml of physiological saline, and 1 ml of this suspension is used to inoculate a 50 ml preculture of the following composition in an I Erlenmeyer flask of capacity 300 ml: 15 Peptone 1 Malt extract 0.5 S" pH 0 The flask is incubated at 30 0 C and 190 rpm in a rotary 20 shaker for 24 hours. 2.5 ml of this culture are used as inoculum for 50 ml of main culture: i Bacilli Peptone 0.12 '.25 Yeast extract 0.12 Glucose 0.25 Na lactate (60 5.6 ml
NH
4 CI 0.12
K
2 HP04 0.12
KH
2
PO
4 0.034 A* MgS04 x 7 H 2 0 0.025 NaCL 0.5 KCL 0.5 CaCI2 x 2 H 2 0 0.0015 i 35 MnCL 2 x 4 H 2 0 0.0007 Fe(NH 4 )citrate 0.00015 The culture is incubated at 28 0 C and a shaking frequency i- -1 @0 0
S
0
S
00 0@ 5.
0S S S @6
S
S S
S.
0 0 0 50 S 40 0 7of 190 rpm for 24 hours and is then harvested by centrifugation.
-fGTP activities of some strains are listed in the table which follows: Strain r'-GTP (mU/ml culture solution) B. subtiLis IFO 3025 IFO 3013 IFO 3335 Example 2 A preculture with Bac. subtilis IFO 3025 is cultured in 15 analogy to Example 1. 50 ml of this culture are used as inoculum for 2 L of main culture solution in a 5 L fermenter. The strain is cultured at 340C and a partial pressure of oxygen of 70 The formation of the -GTP is followed by photometry, and the culture is harvested 20 at the maximum enzyme titer. Under the given conditions, a -GTP titer of 150 mU/ml of culture solution is reached.
Example 3 25 9 L of culture solution are separated by means of crossflow filtration (exclusion limit 300,000 dalton) into culture filtrate and biomass. The culture filtrate obtained in this way contains a P-GTP activity of 1350 U.
The enzyme is precipitated by addition of ammonium sulfate to 70 saturation and is taken up again in 1/10 of the volume. After dialysis against 20 mM tris, pH the enzyme is further purified on a DEAE-cellulose column (DE 52, Whatman). The active eluates are combined and concentrated. A f-GTP product obtained in this way (containing about 25 U of -GTP/ml) is used for the conversions.
4a a 8 Example 4 The following mixture is chosen for preparative conversion of deacetyl-CPC: 100 pL of enzyme concentrate prepared as in Example 3, and 100 pl of 40 mM deacetyl-CPC dissolved in 20 mM potassium phosphate buffer, pH 7.3, are incubated at a temperature of 33 0
C.
Up to 16 deacetyl-7-aminocephalosporanic acid are produced under the chosen conditions.
Example 15 With incubation conditions analogous to those detailed in J o• Example 4, 3 7-aminocephalosporanic acid is liberated from CPC.
Example 6 Determination of -GTP activity 6 S a) HPLC assay 25 50 Lh of 80 mM deacetyl-CPC are mixed with 100 to 140 o pl of 250 mM potassium phosphate buffer, pH 5.0, and 10 to 50 pL of enzyme solution and incubated at 33 C.
A 20 pl-sample is taken every 10 minutes. The reaction is stopped with 20 pl of methanol. It is centrifuged and diluted with water in the ratio 1:10. A 10 pl sample is investigated by HPLC for the 7-aminocephalo- Ssporanic acid content.
i Stationary phase: C-18 silica gel Mobile phase: KH 2
PO
4 50 mM in H 2 0/MeOH (80:20) 0.001 tetrabutylammonium sulfate b) Photometric assay 600 pl of glutamyl-p-nitroaniLide (166 pM) 9- 300 p.L of potassium phosphate buffer, pH 5.7, 50 mM and 100 piL of cuLture solution are mixed together and incubated at 37 0
C.
E 405 9620 1 mo L .c m *4 p
S
S
S. S a.
S *S
S.
d S
S
S
**S
55 0
S.
S.
S 0 5* a 54
S
4.* 0 S 55 0
S
OSS.
'55.
S. S 4 0.
t
Claims (7)
1. Substantially purified y-Glutamyltranspeptidase (y-GTP) having the following characteristics a molecular weight of 40,000 to 80,000, an isoelectric point at pH 4.4 to 5.9, for L- y-glutamylparanitroanilide as substrate a pH optimum in the range 6.5 to 10, and a Km of 9 to 36 ipm at pH 8, and the ability to hydrolyse a-aminoadipinyl-monoamino compounds of the formula I HOOC-CH-(CH 2 3 C-NH-R1 (I) I II NH 2 0 in which R1 denotes amino acids, dipeptides, cephems, cephams or derivatives thereof.
2. y-GTP obtained by fermentation of Bacillus subtilis IFO 3025 having a molecular weight of 40,000 to 80,000, an isoelectric point at pH 4.4 to 5.9, a pH S. optimum of 6.5 to 10 with L-y-Glutamylparanitroanilide as substrate, a Km of 9 to 36 p.m at pH 8 and the ability to catalyse the hydrolysis of a-aminoadipinyl- monoamino compounds of the formula I HOOC-CH-(CH 2 3 C-NH-R1 (I) S|I i II NH 2 O in which R denotes amino acids, dipeptides, cephems, cephams or derivatives thereof.
3. A process for the preparation of the y-GTP as claimed in claim 1 or 2 which comprises cultivation of Bacillus subtilis IFO 3025 in a nutrient medium to elicit production of said y-GTP followed by isolation of said y-GTP. j I 11
4. The use of the y-glutamyltranspeptidase as claimed in claim 1 or 2 for the catalysis of the hydrolysis of a-aminoadipinyl-monoamino compounds of the formula I HOOC-CH-(CH 2 3 C-NH-R1 NH 2 in which R1 denotes amino acids, dipeptides, cephems, cephams or derivatives thereof. The use as claimed in claim 4, wherein the compound of the formula I in which R 1 denotes the radical S N C r F ip o CH R 2 COOH in which R2 is hydrogen, OH or C-CH 3 is hydrolyzed.
I I 0 O
6. The use as claimed in claim 4 or 5, wherein the hydrolysis is carried out at a pH of 6.6 to II.~ 12
7. The use as claimed in one or more of claims 4 to 6, wherein the hydrolysis is carried out at 28 to 380C. DATED this 23rd day of July, 1991. HOECHST AKTIENGESELLSCHAFT WATERMARK PATENT TRADEMARK ATTORNEYS THE ATRIUM 290 BURWOOD ROAD HAWTHORN VICTORIA 3122 AUSTRALIA DBM/KJS/ML o e
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873743323 DE3743323A1 (en) | 1987-12-21 | 1987-12-21 | PROCESS FOR ENZYMATIC HYDROLYSIS OF (ALPHA) -AMINOADIPINYL-MONOAMINO COMPOUNDS |
| DE3743323 | 1987-12-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2732388A AU2732388A (en) | 1989-06-22 |
| AU616450B2 true AU616450B2 (en) | 1991-10-31 |
Family
ID=6343136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU27323/88A Ceased AU616450B2 (en) | 1987-12-21 | 1988-12-20 | A process for the enzymatic hydrolysis of alpha- aminoadipinyl-monoamino compounds |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0321849B1 (en) |
| JP (1) | JP2816167B2 (en) |
| KR (1) | KR0149656B1 (en) |
| AT (1) | ATE91711T1 (en) |
| AU (1) | AU616450B2 (en) |
| CA (1) | CA1317246C (en) |
| CZ (1) | CZ283529B6 (en) |
| DE (2) | DE3743323A1 (en) |
| DK (1) | DK710588A (en) |
| ES (1) | ES2058224T3 (en) |
| HU (1) | HU202917B (en) |
| IE (1) | IE62566B1 (en) |
| PT (1) | PT89282B (en) |
| ZA (1) | ZA889442B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE90382T1 (en) * | 1987-01-17 | 1993-06-15 | Hoechst Ag | USE OF GAMMA GLUTAMYL TRANSPEPTIDASE. |
| US5104800A (en) * | 1989-06-27 | 1992-04-14 | Merck & Co., Inc. | One-step cephalosporin c amidase enzyme |
| US5229274A (en) * | 1989-06-27 | 1993-07-20 | Merck & Co., Inc. | Gene encoding one step cephalosporin C amidase and expression thereof in recombinant bacillus |
| JP3036775B2 (en) * | 1990-02-07 | 2000-04-24 | 協和醗酵工業株式会社 | Method for producing r-glutamyl transpeptidase |
| JPH04281787A (en) * | 1991-03-04 | 1992-10-07 | Yoshihiro Asada | Production of gamma-glutamyltranspeptidase |
| HU219370B (en) * | 1991-10-15 | 2001-03-28 | Gist Brocades Bv | Novel bioprocesses for preparing 7-aca and 7-adac |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1030488A (en) * | 1987-01-17 | 1988-07-21 | Hoechst Aktiengesellschaft | Gamma-glutamyltranspeptidase, its preparation and its use |
| US4774179A (en) * | 1984-07-10 | 1988-09-27 | Asahi Kasei Kogyo Kabushiki Kaisha | Process for preparing a 7-aminocephalosporanic acid compound |
-
1987
- 1987-12-21 DE DE19873743323 patent/DE3743323A1/en not_active Withdrawn
-
1988
- 1988-12-15 AT AT88120945T patent/ATE91711T1/en not_active IP Right Cessation
- 1988-12-15 EP EP88120945A patent/EP0321849B1/en not_active Expired - Lifetime
- 1988-12-15 DE DE8888120945T patent/DE3882503D1/en not_active Expired - Fee Related
- 1988-12-15 ES ES88120945T patent/ES2058224T3/en not_active Expired - Lifetime
- 1988-12-19 ZA ZA889442A patent/ZA889442B/en unknown
- 1988-12-20 IE IE380788A patent/IE62566B1/en not_active IP Right Cessation
- 1988-12-20 JP JP63319704A patent/JP2816167B2/en not_active Expired - Lifetime
- 1988-12-20 PT PT89282A patent/PT89282B/en not_active IP Right Cessation
- 1988-12-20 CZ CS888473A patent/CZ283529B6/en not_active IP Right Cessation
- 1988-12-20 KR KR1019880017019A patent/KR0149656B1/en not_active Expired - Fee Related
- 1988-12-20 CA CA000586515A patent/CA1317246C/en not_active Expired - Fee Related
- 1988-12-20 AU AU27323/88A patent/AU616450B2/en not_active Ceased
- 1988-12-20 DK DK710588A patent/DK710588A/en not_active Application Discontinuation
- 1988-12-20 HU HU886507A patent/HU202917B/en not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4774179A (en) * | 1984-07-10 | 1988-09-27 | Asahi Kasei Kogyo Kabushiki Kaisha | Process for preparing a 7-aminocephalosporanic acid compound |
| AU1030488A (en) * | 1987-01-17 | 1988-07-21 | Hoechst Aktiengesellschaft | Gamma-glutamyltranspeptidase, its preparation and its use |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2816167B2 (en) | 1998-10-27 |
| HU202917B (en) | 1991-04-29 |
| AU2732388A (en) | 1989-06-22 |
| DK710588A (en) | 1989-06-22 |
| CZ847388A3 (en) | 1997-12-17 |
| DK710588D0 (en) | 1988-12-20 |
| DE3743323A1 (en) | 1989-06-29 |
| EP0321849A3 (en) | 1990-09-12 |
| KR0149656B1 (en) | 1998-08-17 |
| EP0321849B1 (en) | 1993-07-21 |
| IE883807L (en) | 1989-06-21 |
| PT89282A (en) | 1989-12-29 |
| KR890010211A (en) | 1989-08-07 |
| DE3882503D1 (en) | 1993-08-26 |
| CZ283529B6 (en) | 1998-04-15 |
| PT89282B (en) | 1993-07-30 |
| CA1317246C (en) | 1993-05-04 |
| ZA889442B (en) | 1989-08-30 |
| EP0321849A2 (en) | 1989-06-28 |
| HUT49168A (en) | 1989-08-28 |
| JPH01199576A (en) | 1989-08-10 |
| ES2058224T3 (en) | 1994-11-01 |
| IE62566B1 (en) | 1995-02-08 |
| ATE91711T1 (en) | 1993-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4774179A (en) | Process for preparing a 7-aminocephalosporanic acid compound | |
| Morin et al. | Production of hydantoinase from Pseudomonas fluorescens strain DSM 84 | |
| AU611406B2 (en) | Gamma-glutamyltranspeptidase, its preparation and its use | |
| US4517299A (en) | Acetylesterases | |
| AU616450B2 (en) | A process for the enzymatic hydrolysis of alpha- aminoadipinyl-monoamino compounds | |
| US5093255A (en) | Acid urease and production thereof | |
| US4275164A (en) | Process and nutrient medium for growing microorganism | |
| JP3093039B2 (en) | Novel esterase A and method for producing the same | |
| JPH05328972A (en) | Novel aminoacylase and its production | |
| US4732857A (en) | Process for producing enzyme capable of inactivating cytosolic aspartate aminotransferase isozyme | |
| EP1397487A2 (en) | Vitamin b6-phosphate phosphatase | |
| US5902736A (en) | Process for the production of D-α-amino acids by hydrolysis of the corresponding N-carbamyl derivative | |
| US5091312A (en) | Process for the preparation of sarcosine oxidase | |
| JPH03133376A (en) | Production of sarcosine oxidase | |
| JPH0634715B2 (en) | Isomaltose degrading enzyme and method for producing the same | |
| JPH07274985A (en) | Process for producing D-γ-methylleucine | |
| JPS632592B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |